Intrathecal Hyperbaric Bupivacaine and Isobaric Levobupivacaine for Spinal Anaesthesia: Block Characteristics and Clinical Effects
Journal Title: Indian Journal of Anesthesia and Analgesia - Year 2019, Vol 6, Issue 2
Abstract
Introduction: Bupivacaine (0.5% heavy) is used to administer subarachnoid block but carries an increased risk of cardiac and central nervous system toxicity if inadvertently injected intravascularly. Levobupivacaine is S-enantiomer of racemic bupivacaine with lesser systemic toxicity. A study was done to compare isobaric levobupivacaine and hyperbaric bupivacaine for spinal anaesthesia in patients undergoing elective lower abdominal surgeries to study hemodynamic variations, sensory and motor blocking properties of these. Methods: A prospective randomized controlled double blind study was conducted in 100 patients of ASA I and II physical status posted for elective lower abdominal surgeries under subarachnoid block, randomized into 2 groups with 50 patients each, received either 3 ml of 0.5% isobaric levobupivacaine (group L) or 3 ml of 0.5% hyperbaric Bupivacaine (group B). Hemodynamic parameters, time for onset of sensory and motor blockade, maximum height of sensory block and total duration of sensory and motor blockade were recorded. Intraoperative or postoperative side effects were noted. Results: The incidence of hypotension and bradycardia were comparable between the two groups. Onset of sensory and motor block (L-2.88 ± 1.81, B-2.12 ± 0.47, p value 0.005, L-3.12 ± 1.62, B-2.28 ± 0.81, p value 0.001, respectively) were significantly delayed in levobupivacaine group. The total duration of sensory block (L- 190.04 ± 35.19, B- 204.02 ± 30.06, p value 0.035) and motor block (L-176.65 ± 40.64, B 204.46 ± 29.8, p value<0.001) were higher in bupivacaine group. Conclusion: 0.5% isobaric levobupivacaine could be an alternative to 0.5% hyperbaric bupivacaine for spinal anaesthesia with similar hemodynamic changes, side effects and shorter durations of sensory and motor blockade.
Authors and Affiliations
Chandana MH
Keywords
Related Articles
- EP ID EP619291
- DOI 10.21088/ijaa.2349.8471.6219.29
- Views 102
- Downloads 0
To Study and Compare Efficacy of Ropivacaine and Bupivacaine for Caudal Analgesia in Paediatric Patients
Aims and objectives: The aim of the study was to compare quality and duration of intra and post operative analgesia and need of rescue analgesia of 0.5 ml/kg of 0.25% Bupivacaine. and 0.5 ml/kg of 0.2% Ropivacaine. Metho...
Comparision of Fentanyl and Dexmedetomidine as Adjuvants to Ropivacaine for Potentiation of Post Operative Analgesia in Femoral Nerve Block for Knee Surgeries
Aims: To compare the effect of addition of Dexmedetomidine (1 ug/kg) and Fentanyl (1 ug/kg) to Ropivacaine (0.2%) in femoral block for potentiation of postoperative analgesia in knee surgeries. Material and methods: Afte...
Haemodynamic Changes in Laryngoscopy with Endotracheal Intubation and Laryngeal Mask Airway Insertion: A Comparative Study in General Surgery Patients
Airway management is must during delivery of general anaesthesia. Previously, laryngoscopy and endotracheal tube (ETT) insertion has been the mainstay in providing adequate airway management and delivering anaesthesia....
Effect of Oral Moxonidine in the Attenuation of the Hemodynamic Responses Seen during Laparoscopic Cholecystectomy: A Clinical Study
Background and Aims: Moxonidine is a selective Imidazoline type 1 receptor agonist. It has a central sympatholytic action and it is used orally as an antihypertensive agent. Selective stimulation of I 1 receptors in the...
Intrathecal Nalbuphine versus Intrathecal Dexmedetomidine for Postoperative Analgesia of Lower Abdominal and Lower Limb Surgeries
ntroduction: Opioids are used as adjuncts with the local anaesthetic for longer duration of action and better postoperative analgesia [4]. Nalbuphine, is a mixed agonist-antagoniste and its analgesic potency is equal to...